BARBAGALLO, Carlo Maria
 Distribuzione geografica
Continente #
NA - Nord America 18.482
EU - Europa 8.347
AS - Asia 7.457
SA - Sud America 1.437
Continente sconosciuto - Info sul continente non disponibili 990
AF - Africa 246
OC - Oceania 67
Totale 37.026
Nazione #
US - Stati Uniti d'America 17.974
SG - Singapore 2.588
RU - Federazione Russa 2.075
CN - Cina 1.850
IT - Italia 1.686
BR - Brasile 1.083
FI - Finlandia 936
HK - Hong Kong 710
DE - Germania 702
VN - Vietnam 692
UA - Ucraina 607
GB - Regno Unito 505
PL - Polonia 495
FR - Francia 362
JP - Giappone 332
IE - Irlanda 295
BD - Bangladesh 291
CA - Canada 263
IN - India 170
SE - Svezia 148
KR - Corea 145
NL - Olanda 124
TR - Turchia 114
MX - Messico 103
AR - Argentina 100
IQ - Iraq 82
AT - Austria 73
CO - Colombia 67
EC - Ecuador 67
AU - Australia 62
IR - Iran 61
PK - Pakistan 61
RO - Romania 56
BE - Belgio 54
ZA - Sudafrica 54
ES - Italia 52
ID - Indonesia 42
MY - Malesia 42
VE - Venezuela 41
MA - Marocco 37
UZ - Uzbekistan 35
CR - Costa Rica 34
JM - Giamaica 32
SA - Arabia Saudita 29
CH - Svizzera 27
CL - Cile 27
CI - Costa d'Avorio 25
PH - Filippine 25
DZ - Algeria 20
KE - Kenya 20
PT - Portogallo 20
EG - Egitto 19
JO - Giordania 19
GR - Grecia 18
TW - Taiwan 18
AE - Emirati Arabi Uniti 17
KZ - Kazakistan 17
NP - Nepal 17
AZ - Azerbaigian 16
HN - Honduras 16
IL - Israele 16
TH - Thailandia 16
PE - Perù 13
PY - Paraguay 13
TT - Trinidad e Tobago 13
LT - Lituania 12
SN - Senegal 12
UY - Uruguay 12
BG - Bulgaria 11
BO - Bolivia 11
DK - Danimarca 11
BA - Bosnia-Erzegovina 10
ET - Etiopia 10
TN - Tunisia 10
AL - Albania 9
EE - Estonia 8
GT - Guatemala 8
PR - Porto Rico 8
CZ - Repubblica Ceca 7
KG - Kirghizistan 7
NO - Norvegia 7
PA - Panama 7
PS - Palestinian Territory 7
QA - Qatar 7
BY - Bielorussia 6
DO - Repubblica Dominicana 6
GH - Ghana 6
HU - Ungheria 6
OM - Oman 6
RS - Serbia 6
LB - Libano 5
NG - Nigeria 5
NI - Nicaragua 5
BB - Barbados 4
HR - Croazia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
SV - El Salvador 4
TG - Togo 4
AO - Angola 3
Totale 35.975
Città #
Ashburn 2.368
Singapore 1.705
San Jose 1.512
Fairfield 1.404
Chandler 884
Woodbridge 730
Hong Kong 680
Houston 647
Wilmington 635
Seattle 609
Council Bluffs 570
Cambridge 464
Zgierz 412
Ann Arbor 393
Moscow 334
Tokyo 312
New York 298
Dallas 297
Medford 290
Jacksonville 289
Dublin 285
Santa Clara 285
Los Angeles 277
Palermo 245
Beijing 236
Frankfurt am Main 218
Ho Chi Minh City 217
Nanjing 202
Des Moines 193
Lauterbourg 184
Princeton 183
Boardman 171
Helsinki 157
Hanoi 156
Altamura 145
San Diego 137
Chicago 135
Hefei 127
Lawrence 107
São Paulo 107
Milan 93
Tulsa 93
Buffalo 85
London 83
Orem 83
Dearborn 82
Rome 66
The Dalles 65
Toronto 65
Atlanta 62
Munich 58
Changsha 57
Amsterdam 56
Hebei 56
Denver 55
Jinan 54
Phoenix 54
Shenyang 54
Nanchang 53
Tianjin 53
Ludwigshafen am Rhein 52
Brooklyn 49
Brussels 47
Montreal 47
San Francisco 46
Warsaw 45
Nuremberg 42
Jiaxing 41
Rio de Janeiro 40
Seongnam 40
Guangzhou 39
Ningbo 38
Izmir 37
Shanghai 37
Bremen 36
Lappeenranta 36
Boston 35
Manchester 33
Ottawa 33
Zhengzhou 33
Chennai 32
Columbus 32
Venice 30
Brasília 29
Hangzhou 29
Haiphong 28
Johannesburg 28
Washington 28
Da Nang 27
Saint Petersburg 27
Dhaka 26
Redwood City 26
Verona 26
Abidjan 25
Paris 25
Philadelphia 25
Tashkent 25
Auburn Hills 24
Belo Horizonte 24
City of London 24
Totale 21.273
Nome #
A century of trends in adult human height 700
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults 668
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment 543
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 populationrepresentative studies with 141 million participants 441
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants 417
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants 358
Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease 309
TERAPIA CON STATINE IN PAZIENTI SICILIANI AFFETTI DA IPERLIPIDEMIA FAMILIARE COMBINATA 308
CEREBROTENDINOUS XANTHOMATOSIS: A SICILIAN FAMILY HARBOURING THE R362C MUTATION IN THE STEROL 27-HYDROXYLASE GENE 306
ApoE polymorphism in a small Mediterranean island: Relationships with plasma lipids, lipoproteins and LDL particle size 291
Interleukin 6 plasma levels predict with high sensitivity and specificity coronary stenosis detected by coronary angiography 286
A NOVEL COMPOUND HETEROZYGOUS MUTATION OF THE LIPOPROTEIN LIPASE GENE IN A NEWBORN WITH CHYLOMICRONEMIA 285
CLINICAL AND MOLECULAR CHARACTERIZATION OF HYPERCHOLESTEROLEMIC SICILIAN FAMILIES AND DESCRIPTION OF 3 NOVEL MUTATIONS IN THE LDLR GENE 284
A NOVEL NONSENSE MUTATION IN THE CETP GENE IN ITALIAN HYPERALPHALIPOPROTEINEMIC SUBJECTS 278
BETA-2-GLYCOPROTEIN I IS GROWTH REGULATED AND PLAYS A ROLE AS SURVIVAL FACTOR FOR HEPATOCYTES 273
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred 273
REDUCTION OF CHOLESTEROL WITH NUTRACEUTICAL: RESULTS OF A DOUBLE BLIND STUDY 270
Six novel mutations of the LDL receptor gene in FH kindred of Sicilian and Paraguayan descent 267
Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population 261
PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study 259
PREVALENCE OF APOB VARIANTS IN A SAMPLE OF SUBJECTS WITH HYPOCHOLESTEROLEMIA 258
The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: Results of a 15 years follow-up in a Mediterranean population. 256
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 256
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants 254
INTERLEUKIN 6 PLASMA LEVELS PREDICT WITH HIGH SENSITIVITY AND SPECIFICITY CORONARY STENOSIS DETECTED BY CORONARY ANGIOGRAPHY 249
Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients. 249
Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia. 248
Genotypic and phenotypic characterization of patients with autosomal dominant hypercholesterolemia in sicily 241
HYPOBETALIPOPROTEINEMIA AND FATTY LIVER: WHO IS THE CULPRIT 240
Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis 239
REPOSITIONING OF THE GLOBAL EPICENTRE OF NON-OPTIMAL CHOLESTEROL 233
Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population 232
LA LIPIDOMICA DELLA NON ALCOHOLIC FATTY LIVER DISEASE: ANALISI DELLA CINETICA DELL’ACIDO PALMITICO MEDIANTE L’USO DI UN ISOTOPO STABILE IN UN MODELLO IN VITRO 231
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing 231
Albumin versus solvent/detergent-treated pooled plasma as replacement fluid for long-term plasma exchange therapy in a patient with primary hypertriglyceridemia and recurrent hyperlipidemic pancreatitis 229
Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study 228
Association of Overweight With Increased Risk of Coronary Heart Disease Partly Independent of Blood Pressure and Cholesterol Levels A Meta-analysis of 21 Cohort Studies Including More Than 300 000 Persons. 228
The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. 226
LDL peak particle size and the extension of coronary atherosclerosis in 72 patients that underwent an angiographic exam 226
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults 222
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331 288 participants 221
Influence of Calendar Period on the Association Between BMI and Coronary Heart Disease: A Meta-Analysis of 31 Cohorts 220
FAMILIAL LIGAND-DEFECTIVE APOLIPOPROTEIN B: IDENTIFICATION OF A FAMILY HARBOURING THE ARG3531CYS (FDB3531) OF THE APOB GENE 219
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 219
DIFFERENCE IN THE PREVALENCE OF METABOLIC SYNDROME AND CARDIOVASCULAR RISK FACTORS AFTER 14 YEARS IN THE POPULATION OF VENTIMIGLIA DI SICILIA 217
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene. 217
Myristic acid is associated to low plasma HDL cholesterol levels in a Mediterranean population and increases HDL catabolism by enhancing HDL particles trapping to cell surface proteoglycans in a liver hepatoma cell model 217
Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity. 216
ENHANCED LIPID PEROXIDATION AND PLATELET ACTIVATION AS POTENTIAL CONTRIBUTORS TO INCREASED CARDIOVASCULAR RISK IN THE LOW-HDL PHENOTYPE. 215
Determinants of enhanced thromboxane biosynthesis in renal transplantation 215
Dietary strategy for prevention and management of dyslipidemia: International guidelines 214
Trends in Adult Body-Mass Index in 200 Countries From 1975 to 2014: A Pooled Analysis of 1698 Population-Based Measurement Studies With 19·2 Million Participants 214
UNA NUOVA MUTAZIONE DELL’INTRONE 16 (G>A a 2390 -1) DEL RECETTORE DELLE LDL RESPONSABILE DI IPERCOLESTEROLEMIA FAMILIARE. EFFETTI SULLA ESPRESSIONE DELL’mRNA DEL RECETTORE DELLE LDL 213
MISSENSE MUTATION ALA34VAL IN EXON 2 OF THE LIPOPROTEIN LIPASE GENE IN A YOUNG MAN WITH CHYLOMICRONEMIA. 212
Role of Nutraceuticals in Hypolipidemic Therapy 212
Cystatin C levels are decreased in acute myocardial infarction: Effect of cystatin C G73A gene polymorphism on plasma levels 211
A novel nonsense mutation in the cept gene in italian Hyperalphalipoproteinemic subjects 208
Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction 208
Genetic epidemiology of ARH in Sicily 206
Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia 205
COMPOUND HETEROZYGOUS FH AND FDB: IDENTIFICATION OF A SICILIAN FAMILY HARBOURING THE FDB3531 MUTATION AND THE Y398X MUTATION OF THE LDL RECEPTOR GENE. 205
ASSOCIAZIONE DEL POLIMORFISMO Q192R DEL GENE DELLA PARAOXONASI I (PON1) CON LA MALATTIA CORONARICA IN UN CAMPIONE DI PZ CON INFARTO MIOCARDICO, MALATTIA CORONARICA NON INFARTUALE E SOGGETTI NORMALI. 203
Le LDL generate in fase post-prandiale dopo carico grasso presentano maggiore densita’, minore size e maggiore affinita’ per il recettore 203
Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia 202
The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction 202
Diabetes, family hystory and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study 201
NOVEL NONSENSE MUTATION IN THE CETP GENE IN ITALIAN HYPERALPHALIPOPROTEINEMIC SUBJECTS 201
MUTAZIONI DEL GENE DELL’APOB RESPONSABILI DI IPOBETALIPOPROTEINEMIA FAMILIARE IN SICILIA 200
ENHANCED LIPID PEROXIDATION AND PLATELET ACTIVATION AS POTENTIAL CONTRIBUTORS TO INCREASED CARDIOVASCULAR RISK IN THE “LOW-HDL” PHENOTYPE. 199
MUSCLE DAMAGE AND PAIN IN HYPERCHOLESTEROLEMIC OUT-PATIENTS POPULATION ON STATIN TREATMENT. 199
Esiste un pattern ecografico associato alla steatosi capace di facilitare il suo riconoscimento etiologico? 199
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography 199
IDENTIFICATION OF A HETEROZYGOUS COMPOUND INDIVIDUAL WITH AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA HARBOURING A MUTATION IN THE LDL-R GENE AND IN THE PCSK9 GENE 198
PREVALENCE OF CAROTID LESIONS IN A MEDITERRANEAN POPULTION OF HYPERTENSIVES 198
Plasma levels of lipoproteins and apolipoproteins in congenital hypothyroidism: effects of L-thyroxine substitution therapy 198
Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol–diabetes connection? A systematic review of literature 198
NEXT GENERATION SEQUENCIN: A NEW METHODOLOGICAL APPROACH FOR THE MOLECULAR DIAGNOSIS OF GENETIC DYSLIPIDEMIAS 197
FAMILIAL HYPOBETALIPOPROTEINEMIA DUE TO APOLIPOPROTEIN B GENE MUTATIONS CAUSES INTESTINAL FAT ACCUMULATION AND LIPID MALABSORPTION. 194
FAMILIAL HYPOALPHALIPOPROTEINEMIA ASSOCIATED TO CORNEAL OPACITIES IN ABSENCE OF LCAT DEFICIENCY 189
Effects “beyond-cholesterol” by statins: a 3-months therapy with simvastatin reduces the atherogenic lipoproteins in patients with premature coronary artery disease and in absence of the traditional cardiovascular risk factors. 189
DETECTION OF NEW GENES RESPONSIBLE OF FAMILIAL RECESSIVE HYPERCHOLESTEROLEMIA: PRELIMINARY DATA FROM AN EXOME SEQUENCING APPROACH 189
Anti-PCSK9 treatment: Is ultra-low LDL always good? 189
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants 189
HETEROGENITY OF AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA IN SICILY 188
NONSENSE MUTATION IN THE CETP GENE IN ITALIAN HYPERALPHALIPOPROTEINEMIC SUBJECTS. 186
Prevalence of overweight and obesity in a rural southern Italy population and relationships with total and cardiovascular mortality: The Ventimiglia di Sicilia project 186
THE METABOLIC SYNDROME IS A PREDICTOR OF CARDIOVASCULAR EVENTS IN A SICILIAN POPULATION. RESULT OF A 15 YEARS FOLLOW UP 185
Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants 184
Descrizione di una famiglia siciliana con iper-alfa-lipoproteinemia con deficit di CETP 181
Metabolic disturbances and risk of cancer in the 25 years follow-up of the “Ventimiglia Heart Study” epidemiological project 179
Leukocyte count, diabetes mellitus and age are strong predictors of stroke in a rural population in southern Italy: An 8-year follow-up 178
EFFETTI “BEYOND CHOLESTEROL” DELLE STATINE 177
Genetic heterogeneity of familial hypercholesterolemia in Sicily 176
Identification of a novel ANGPTL3 mutation splicing associeted to severe hypobetalipoproteinemia 176
National, regional, and global trends in adult overweight and obesity prevalences 176
Italian familial defective apolipoprotein B patients share a unique haplotype with other Caucasian patients 175
USE OF THE DRUG ELUTING STENTS WITH RAPAMICIN IN PATIENTS WITH ANATOMICAL OR CLINICAL PATTERNS FAVOURING RESTENOSIS: RESULTS OF A 6-MONTHS FOLLOW-UP ON THE FIRST 100 PATIENS. 174
Nutritional characteristics of a rural Southern Italy population: the Ventimiglia di Sicilia Project 174
THE METABOLIC SYNDROME PREDICTS CARDIOVASCULAR EVENTS IN SUBJECTS WITH NORMAL FASTING GLUCOSE. A FIFTEEN YEARS FOLLOW-UP IN A MEDITERRANEAN POPULATION 170
Accumulo di VLDL/IDL contenenti ApoE in maschi normolipemici con cardiopatia ischemica precoce 170
Totale 23.708
Categoria #
all - tutte 120.564
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.564


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.549 0 0 0 59 50 81 79 115 342 313 94 416
2022/20232.728 325 444 69 286 320 421 167 200 298 24 113 61
2023/20241.420 71 187 106 160 80 355 144 47 51 39 29 151
2024/20253.413 79 209 216 291 128 159 257 252 337 372 433 680
2025/202612.905 802 442 693 972 1.192 1.871 1.687 1.322 1.018 1.895 509 502
2026/20274.376 743 713 2.443 477 0 0 0 0 0 0 0 0
Totale 37.026